PYC THERAPEUTICS LIMITED - Announcements

6.43%

$1.33

Market Cap $772.8M

Healthcare Biotechnology

PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company... PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company creating a new generation of ribonucleic acid (RNA) therapies to change the lives of patients with genetic diseases. The Company utilizes its proprietary drug delivery platform to enhance the potency of precision medicines within the rapidly growing and commercially proven RNA therapeutic class. Its drug development programs target monogenic diseases - the indications with the highest likelihood of success in clinical development. Its first-in-class drug programs include Retinitis Pigmentosa type 11, (VP-001), Polycystic Kidney Disease, (PYC-003), Autosomal Dominant Optic Atrophy (ADOA) (PYC-001) and Phelan-McDermid Syndrome (PMS) (PYC-002). The Company's VP-001 program is a lead asset for a blinding eye disease of childhood progressed through multiple patient cohorts in the ongoing single ascending dose clinical trial. ADOA is a progressive and blinding eye disease.More

Actinogen Medical (ASX:ACW) reaches 100th participant milestone in Alzheimer’s Disease Trial & confirms interim analysis timeline.

Announcements

Filter Results

All Price Sensitive Only

PYC	Half Year Accounts	PRICE SENSITIVE	27/02/12	442.57KB	Share
PYC	US Patent granted	PRICE SENSITIVE	23/02/12	117.88KB	Share
PYC	Change of Director's Interest Notice		22/02/12	112.04KB	Share
PYC	Change of Director's Interest Notice		22/02/12	115.63KB	Share
PYC	NAOS Increases Shareholding to 11.5%	PRICE SENSITIVE	02/02/12	27.11KB	Share
PYC	Ceasing to be a substantial holder		31/01/12	45.21KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/12	74.58KB	Share
PYC	Change in substantial holding		13/01/12	65.66KB	Share
PYC	Change of Director's Interest Notice		12/01/12	74.39KB	Share
PYC	Change of Director's Interest Notice		05/01/12	113.93KB	Share
PYC	Shareholder Update		03/01/12	24.07KB	Share
PYC	Technology Licence to Janssen Biotech	PRICE SENSITIVE	03/01/12	24.47KB	Share
PYC	Notice Under Section 708A		21/12/11	24.87KB	Share
PYC	Appendix 3B		21/12/11	349.55KB	Share
PYC	Ceasing to be a substantial holder		16/12/11	93.51KB	Share
PYC	Share Placement raises $2.15 Million	PRICE SENSITIVE	14/12/11	120.02KB	Share
PYC	Pfizer First Stage of Collaboration Complete	PRICE SENSITIVE	12/12/11	27.95KB	Share
PYC	Trading Halt	PRICE SENSITIVE	12/12/11	22.07KB	Share
PYC	Results of Meeting		24/11/11	21.66KB	Share
PYC	Presentation to Shareholders		24/11/11	3.23MB	Share
PYC	MedImmune Antibiotic Discovery Partnership	PRICE SENSITIVE	21/11/11	28.52KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	01/11/11	69.47KB	Share
PYC	Annual Report to shareholders		24/10/11	3.55MB	Share
PYC	Notice of Annual General Meeting/Proxy Form		24/10/11	108.97KB	Share
PYC	Details of Company Address		07/10/11	19.9KB	Share
PYC	Full Year Statutory Accounts		27/09/11	439.73KB	Share
PYC	Appendix 3B		05/09/11	150.38KB	Share
PYC	Broker Research Report		01/09/11	27.8KB	Share
PYC	Change of Director's Interest Notice		01/09/11	108.91KB	Share
PYC	Change of Director's Interest Notice		01/09/11	110.05KB	Share
PYC	Preliminary Final Report	PRICE SENSITIVE	31/08/11	36.4KB	Share
PYC	Life Sciences Showcase 2011		19/08/11	21.07KB	Share
PYC	Expiry of Options		01/08/11	32.11KB	Share
PYC	Change of Director's Interest Notice		01/08/11	106.7KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/11	70.36KB	Share
PYC	Letter to Optionholders		27/07/11	20.64KB	Share
PYC	Edison Investment Research Report		08/07/11	28.84KB	Share
PYC	Change in substantial holding		20/06/11	160.38KB	Share
PYC	NAOS Asset Management 10.2% shareholder		10/06/11	32.55KB	Share
PYC	Change in substantial holding		26/05/11	65.93KB	Share
PYC	Progress on Cell Penetrating Peptides	PRICE SENSITIVE	25/05/11	4.87MB	Share
PYC	Response to ASX Query		23/05/11	60.57KB	Share
PYC	Roche Collaboration Extended	PRICE SENSITIVE	23/05/11	33.69KB	Share
PYC	Change in substantial holding		20/05/11	153.36KB	Share
PYC	Change of Director's Interest Notice		19/05/11	107.03KB	Share
PYC	Change of Director's Interest Notice		19/05/11	106.66KB	Share
PYC	Change of Director's Interest Notice		19/05/11	111.21KB	Share
PYC	Becoming a substantial holder		18/05/11	64.2KB	Share
PYC	Appendix 3B		16/05/11	151.82KB	Share
BTC +PYC	Ceasing to be a substantial holder from BTC		11/05/11	325.73KB	Share
PYC	Results of Meeting		10/05/11	25.51KB	Share
PYC	Collaboration with PEPSCAN	PRICE SENSITIVE	10/05/11	94.47KB	Share
PYC	Appendix 3B		05/05/11	149.24KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/11	40.82KB	Share
PYC	New US Screening Patent Granted	PRICE SENSITIVE	11/04/11	45.07KB	Share
PYC	Notice of General Meeting/Proxy Form		08/04/11	96.8KB	Share
PYC	Corporate Changes		05/04/11	39.45KB	Share
PYC	Appendix 3B 1st Tranche B		04/04/11	193.68KB	Share
PYC	Appendix 3B 1st Tranche A		01/04/11	230.79KB	Share
PYC	Cleansing disclosure document		30/03/11	2.27MB	Share
PYC	Appendix 3B first tranche placement		25/03/11	184.07KB	Share
PYC	Phylogica Limited Share Placement raises $5.2 million	PRICE SENSITIVE	25/03/11	84.87KB	Share
PYC	Trading Halt	PRICE SENSITIVE	23/03/11	24.62KB	Share
PYC	Shareholder Update March 2011		15/03/11	380.88KB	Share
PYC	Phylogica Discovery Spin-Off with University of Cambridge	PRICE SENSITIVE	09/03/11	97.85KB	Share
PYC	Appendix 3B		03/03/11	165.58KB	Share
PYC	Half Yearly Report and Accounts	PRICE SENSITIVE	24/02/11	242.56KB	Share
PYC	Phylogica - Isogenica Technology Collaboration	PRICE SENSITIVE	23/02/11	35.65KB	Share
BTC +PYC	Clarification of change in substantial holding in PYC		22/02/11	77.7KB	Share
BTC +PYC	Change in substantial holding from BTC		22/02/11	735.6KB	Share
PYC	Phylogica - New Potential For Treating Brain Injury	PRICE SENSITIVE	21/02/11	102.21KB	Share
PYC	Phylogica Announces Successful Collaboration with Roche	PRICE SENSITIVE	17/02/11	83.75KB	Share
PYC	FNN interview N Woolf Pfizer Deal, Goals for 2011	PRICE SENSITIVE	17/02/11	147.27KB	Share
PYC	Shareholder Update February 2011		07/02/11	776.23KB	Share
PYC	Change of Substantial Holding - Correction		03/02/11	158.41KB	Share
PYC	Change in substantial holding		03/02/11	156.28KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/11	59.65KB	Share
PYC	Phylogica Named as One of Bioshares 'Top 10 Picks' for 2011		25/01/11	77.86KB	Share
PYC	Phylogica Receives Prestigious Frost and Sullivan Award		24/01/11	131.7KB	Share
PYC	Phylogica Accesses Novel Half-Life Extension Technology	PRICE SENSITIVE	13/01/11	31.68KB	Share
PYC	Share Trading Policy		23/12/10	68.27KB	Share
PYC	Phylogica Signs Collaboration and Licensing Deal with Pfizer	PRICE SENSITIVE	20/12/10	86.62KB	Share
PYC	Appendix 3B AGM issues		17/12/10	165.85KB	Share
PYC	Change of Director's Interest Notice		17/12/10	23.05KB	Share
PYC	Interview Nick Woolf CFO and VP Corp Development	PRICE SENSITIVE	16/12/10	96.12KB	Share
PYC	Chairman's Update 2010		07/12/10	236.94KB	Share
PYC	Final Director's Interest Notice		06/12/10	252.14KB	Share
PYC	AGM presentation		30/11/10	1.39MB	Share
PYC	Results of Meeting		30/11/10	31.3KB	Share
PYC	MedImmune drug discovery activities commence	PRICE SENSITIVE	02/11/10	24.48KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	29/10/10	56.92KB	Share
PYC	Annual Report to shareholders		28/10/10	1.01MB	Share
PYC	Notice of Annual General Meeting/Proxy Form		28/10/10	237.64KB	Share
PYC	Roche Ausbiotech 2010 congress - Phylogica Partnership		21/10/10	201.18KB	Share
PYC	PHYLOGICA AND ROCHE COMPLETE FIRST STAGE OF PARTNERSHIP	PRICE SENSITIVE	21/10/10	79.1KB	Share
PYC	Change in substantial holding		15/10/10	88.55KB	Share
PYC	Executive role appointment - N Woolf		14/10/10	21.97KB	Share
PYC	Change in substantial holding		13/10/10	157.16KB	Share
PYC	Appendix 3B rights issue Underwriting		08/10/10	183.63KB	Share
PYC	Australian Life Science Report		07/10/10	21.51KB	Share

PYCHalf Year Accounts
27/02/12	PRICE SENSITIVE	442.57KB	Share
PYCUS Patent granted
23/02/12	PRICE SENSITIVE	117.88KB	Share
PYCChange of Director's Interest Notice
22/02/12		112.04KB	Share
PYCChange of Director's Interest Notice
22/02/12		115.63KB	Share
PYCNAOS Increases Shareholding to 11.5%
02/02/12	PRICE SENSITIVE	27.11KB	Share
PYCCeasing to be a substantial holder
31/01/12		45.21KB	Share
PYCAppendix 4C - quarterly
31/01/12	PRICE SENSITIVE	74.58KB	Share
PYCChange in substantial holding
13/01/12		65.66KB	Share
PYCChange of Director's Interest Notice
12/01/12		74.39KB	Share
PYCChange of Director's Interest Notice
05/01/12		113.93KB	Share
PYCShareholder Update
03/01/12		24.07KB	Share
PYCTechnology Licence to Janssen Biotech
03/01/12	PRICE SENSITIVE	24.47KB	Share
PYCNotice Under Section 708A
21/12/11		24.87KB	Share
PYCAppendix 3B
21/12/11		349.55KB	Share
PYCCeasing to be a substantial holder
16/12/11		93.51KB	Share
PYCShare Placement raises $2.15 Million
14/12/11	PRICE SENSITIVE	120.02KB	Share
PYCPfizer First Stage of Collaboration Complete
12/12/11	PRICE SENSITIVE	27.95KB	Share
PYCTrading Halt
12/12/11	PRICE SENSITIVE	22.07KB	Share
PYCResults of Meeting
24/11/11		21.66KB	Share
PYCPresentation to Shareholders
24/11/11		3.23MB	Share
PYCMedImmune Antibiotic Discovery Partnership
21/11/11	PRICE SENSITIVE	28.52KB	Share
PYCAppendix 4C - quarterly
01/11/11	PRICE SENSITIVE	69.47KB	Share
PYCAnnual Report to shareholders
24/10/11		3.55MB	Share
PYCNotice of Annual General Meeting/Proxy Form
24/10/11		108.97KB	Share
PYCDetails of Company Address
07/10/11		19.9KB	Share
PYCFull Year Statutory Accounts
27/09/11		439.73KB	Share
PYCAppendix 3B
05/09/11		150.38KB	Share
PYCBroker Research Report
01/09/11		27.8KB	Share
PYCChange of Director's Interest Notice
01/09/11		108.91KB	Share
PYCChange of Director's Interest Notice
01/09/11		110.05KB	Share
PYCPreliminary Final Report
31/08/11	PRICE SENSITIVE	36.4KB	Share
PYCLife Sciences Showcase 2011
19/08/11		21.07KB	Share
PYCExpiry of Options
01/08/11		32.11KB	Share
PYCChange of Director's Interest Notice
01/08/11		106.7KB	Share
PYCAppendix 4C - quarterly
29/07/11	PRICE SENSITIVE	70.36KB	Share
PYCLetter to Optionholders
27/07/11		20.64KB	Share
PYCEdison Investment Research Report
08/07/11		28.84KB	Share
PYCChange in substantial holding
20/06/11		160.38KB	Share
PYCNAOS Asset Management 10.2% shareholder
10/06/11		32.55KB	Share
PYCChange in substantial holding
26/05/11		65.93KB	Share
PYCProgress on Cell Penetrating Peptides
25/05/11	PRICE SENSITIVE	4.87MB	Share
PYCResponse to ASX Query
23/05/11		60.57KB	Share
PYCRoche Collaboration Extended
23/05/11	PRICE SENSITIVE	33.69KB	Share
PYCChange in substantial holding
20/05/11		153.36KB	Share
PYCChange of Director's Interest Notice
19/05/11		107.03KB	Share
PYCChange of Director's Interest Notice
19/05/11		106.66KB	Share
PYCChange of Director's Interest Notice
19/05/11		111.21KB	Share
PYCBecoming a substantial holder
18/05/11		64.2KB	Share
PYCAppendix 3B
16/05/11		151.82KB	Share
BTC +PYCCeasing to be a substantial holder from BTC
11/05/11		325.73KB	Share
PYCResults of Meeting
10/05/11		25.51KB	Share
PYCCollaboration with PEPSCAN
10/05/11	PRICE SENSITIVE	94.47KB	Share
PYCAppendix 3B
05/05/11		149.24KB	Share
PYCAppendix 4C - quarterly
29/04/11	PRICE SENSITIVE	40.82KB	Share
PYCNew US Screening Patent Granted
11/04/11	PRICE SENSITIVE	45.07KB	Share
PYCNotice of General Meeting/Proxy Form
08/04/11		96.8KB	Share
PYCCorporate Changes
05/04/11		39.45KB	Share
PYCAppendix 3B 1st Tranche B
04/04/11		193.68KB	Share
PYCAppendix 3B 1st Tranche A
01/04/11		230.79KB	Share
PYCCleansing disclosure document
30/03/11		2.27MB	Share
PYCAppendix 3B first tranche placement
25/03/11		184.07KB	Share
PYCPhylogica Limited Share Placement raises $5.2 million
25/03/11	PRICE SENSITIVE	84.87KB	Share
PYCTrading Halt
23/03/11	PRICE SENSITIVE	24.62KB	Share
PYCShareholder Update March 2011
15/03/11		380.88KB	Share
PYCPhylogica Discovery Spin-Off with University of Cambridge
09/03/11	PRICE SENSITIVE	97.85KB	Share
PYCAppendix 3B
03/03/11		165.58KB	Share
PYCHalf Yearly Report and Accounts
24/02/11	PRICE SENSITIVE	242.56KB	Share
PYCPhylogica - Isogenica Technology Collaboration
23/02/11	PRICE SENSITIVE	35.65KB	Share
BTC +PYCClarification of change in substantial holding in PYC
22/02/11		77.7KB	Share
BTC +PYCChange in substantial holding from BTC
22/02/11		735.6KB	Share
PYCPhylogica - New Potential For Treating Brain Injury
21/02/11	PRICE SENSITIVE	102.21KB	Share
PYCPhylogica Announces Successful Collaboration with Roche
17/02/11	PRICE SENSITIVE	83.75KB	Share
PYCFNN interview N Woolf Pfizer Deal, Goals for 2011
17/02/11	PRICE SENSITIVE	147.27KB	Share
PYCShareholder Update February 2011
07/02/11		776.23KB	Share
PYCChange of Substantial Holding - Correction
03/02/11		158.41KB	Share
PYCChange in substantial holding
03/02/11		156.28KB	Share
PYCAppendix 4C - quarterly
28/01/11	PRICE SENSITIVE	59.65KB	Share
PYCPhylogica Named as One of Bioshares 'Top 10 Picks' for 2011
25/01/11		77.86KB	Share
PYCPhylogica Receives Prestigious Frost and Sullivan Award
24/01/11		131.7KB	Share
PYCPhylogica Accesses Novel Half-Life Extension Technology
13/01/11	PRICE SENSITIVE	31.68KB	Share
PYCShare Trading Policy
23/12/10		68.27KB	Share
PYCPhylogica Signs Collaboration and Licensing Deal with Pfizer
20/12/10	PRICE SENSITIVE	86.62KB	Share
PYCAppendix 3B AGM issues
17/12/10		165.85KB	Share
PYCChange of Director's Interest Notice
17/12/10		23.05KB	Share
PYCInterview Nick Woolf CFO and VP Corp Development
16/12/10	PRICE SENSITIVE	96.12KB	Share
PYCChairman's Update 2010
07/12/10		236.94KB	Share
PYCFinal Director's Interest Notice
06/12/10		252.14KB	Share
PYCAGM presentation
30/11/10		1.39MB	Share
PYCResults of Meeting
30/11/10		31.3KB	Share
PYCMedImmune drug discovery activities commence
02/11/10	PRICE SENSITIVE	24.48KB	Share
PYCAppendix 4C - quarterly
29/10/10	PRICE SENSITIVE	56.92KB	Share
PYCAnnual Report to shareholders
28/10/10		1.01MB	Share
PYCNotice of Annual General Meeting/Proxy Form
28/10/10		237.64KB	Share
PYCRoche Ausbiotech 2010 congress - Phylogica Partnership
21/10/10		201.18KB	Share
PYCPHYLOGICA AND ROCHE COMPLETE FIRST STAGE OF PARTNERSHIP
21/10/10	PRICE SENSITIVE	79.1KB	Share
PYCChange in substantial holding
15/10/10		88.55KB	Share
PYCExecutive role appointment - N Woolf
14/10/10		21.97KB	Share
PYCChange in substantial holding
13/10/10		157.16KB	Share
PYCAppendix 3B rights issue Underwriting
08/10/10		183.63KB	Share
PYCAustralian Life Science Report
07/10/10		21.51KB	Share

REFRESH

First 6 7 8 9 10

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.33		Change 0.080(6.43%)		Mkt cap ! $772.8M

Open	High	Low	Value	Volume
$1.27	$1.35	$1.21	$763.8K	595.4K

Buyers (Bids)

No.	Vol.	Price($)
2	97719	$1.30

Sellers (Offers)

Price($)	Vol.	No.
$1.33	6599	1

View Market Depth

No.	Vol.	Price($)
2	97719	1.300
1	4027	1.240
1	40000	1.220
1	1000	1.200
2	10830	1.190

Price($)	Vol.	No.
1.325	6599	1
1.395	7168	1
1.400	18450	1
1.420	26097	2
1.430	13000	1

Last trade - 16.10pm 08/08/2025 (20 minute delay)

PYC (ASX) Chart

PYC THERAPEUTICS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories